Home » Topics » BioWorld Science

BioWorld Science
RSS

Albenza receives U.S. marketing approval

June 21, 1996

Y-ART-3: Promising HIV treatment candidate

June 21, 1996

HIV protease inhibitors from Warner-Lambert

June 21, 1996

Alpha-glucosidase inhibitors from Seikagaku Kogyo

June 21, 1996

Positive analysis results for Amphotec

June 21, 1996

AmBisome line extension receives Danish approval

June 21, 1996

FDA approves abbreviated treatment regimen for Vantin

June 21, 1996

Antifungal sordarin derivatives reported by Glaxo Wellcome

June 21, 1996

Collagen Corporation and Biomatrix enter marketing agreement

June 21, 1996

KCB-1 skin ulcer clinical trials completed

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...